Zimmer Biomet Holdings, INC Form 4 insider transactions
Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.
NYSE
Michael J. Farrell, a Director of Zimmer Biomet Holdings, Inc., received 417 shares of common stock on September 30, 2026.
NYSE
Robert Hagemann, a Director of Zimmer Biomet Holdings, Inc., received 306 shares of common stock on September 30, 2026.
NYSE
Arthur J Higgins, a Director of Zimmer Biomet Holdings, Inc., received 306 shares of common stock on September 30, 2026.
NYSE
Louis Shapiro, a Director of Zimmer Biomet Holdings, Inc., received 153 shares of common stock on September 30, 2026.
NYSE
Maria Teresa Hilado, a Director of Zimmer Biomet Holdings, Inc., received 376 shares of common stock on September 30, 2026.
NYSE
Devdatt Kurdikar, a Director of Zimmer Biomet Holdings, Inc., received 174 shares of common stock on September 30, 2026.
NYSE
Sreelakshmi Kolli, a Director of Zimmer Biomet Holdings, Inc., received 174 shares of common stock on September 30, 2026.
NYSE
Kevin R Thornal, Grp Pres-Global Business of Zimmer Biomet Holdings, Inc., sold 5,691 shares of common stock on September 11, 2026 for $92.95 per share.
NYSE
Chad F Phipps, See remarks below. of Zimmer Biomet Holdings, Inc., sold 3,000 shares of common stock on September 4, 2026 for $98.35 per share.
NYSE
Kevin R Thornal, Grp Pres-Global Business of Zimmer Biomet Holdings, Inc., reported multiple transactions in common stock on August 1, 2026.
NYSE
Maria Teresa Hilado, a Director at Zimmer Biomet Holdings, Inc., reported transactions involving phantom stock units under the company's Deferred Compensation Plan for Non-Employee Directors.
NYSE
Zimmer Biomet Holdings, Inc. Director Devdatt Kurdikar reported the accrual of 180.323 phantom stock units under the company's Deferred Compensation Plan for Non-Employee Directors.
NYSE
Robert Hagemann, a Director at Zimmer Biomet Holdings, Inc., has reported transactions related to phantom stock units under the company's Deferred Compensation Plan for Non-Employee Directors.
NYSE
Arthur J. Higgins, a Director at Zimmer Biomet Holdings, Inc., reported the acquisition of phantom stock units under the company's Deferred Compensation Plan for Non-Employee Directors.
NYSE
Director Sreelakshmi Kolli of Zimmer Biomet Holdings, Inc. has reported transactions related to phantom stock units, indicating changes in beneficial ownership.
NYSE
Michael J. Farrell, a Director at Zimmer Biomet Holdings, Inc., reported transactions involving phantom stock units under the company's Deferred Compensation Plan for Non-Employee Directors.
NYSE
Zimmer Biomet Holdings, Inc. reports that Jehanzeb Noor, Senior Vice President, Chief Strategy, Innovation & Business Development Officer, acquired 1,857 Restricted Stock Units on June 1, 2026.
NYSE
Zimmer Biomet Holdings, Inc. reports insider transactions involving the sale of common stock by Group President, Asia Pacific, Sang Yi.
NYSE
Michael J. Farrell, a Director at Zimmer Biomet Holdings, Inc., reported transactions involving phantom stock units and restricted stock units.
NYSE
Betsy J. Bernard, a Director at Zimmer Biomet Holdings, Inc., reported transactions involving phantom stock units and restricted stock units.
NYSE
Maria Teresa Hilado, a Director at Zimmer Biomet Holdings, Inc., reported transactions involving phantom stock units and restricted stock units.
NYSE
Louis Shapiro, a Director at Zimmer Biomet Holdings, Inc., reported transactions involving phantom stock units and restricted stock units.
NYSE
Director Devdatt Kurdikar of Zimmer Biomet Holdings, Inc. reported transactions involving phantom stock units and restricted stock units.
NYSE
Zimmer Biomet Holdings, Inc. Director Sreelakshmi Kolli has reported transactions involving phantom stock units and restricted stock units.
NYSE
Syed A. Jafry, a Director at Zimmer Biomet Holdings, Inc., reported transactions involving phantom stock units and restricted stock units.
NYSE
Arthur J. Higgins, a Director at Zimmer Biomet Holdings, Inc., reported transactions involving phantom stock units and restricted stock units.
NYSE
Director Robert Hagemann of Zimmer Biomet Holdings, Inc. reported transactions involving phantom stock units and restricted stock units.
NYSE
Paul A. Stellato, VP, Controller, CAO of Zimmer Biomet Holdings, Inc., was granted 9,232 Restricted Stock Units on May 1, 2026.
NYSE
Zimmer Biomet Holdings, Inc. reports insider transactions, with Noor Jehanzeb acquiring shares and RSUs.
NYSE
Director Syed A. Jafry acquired 182.421 phantom stock units under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan.